Biopsychosoc Med. 2009 Oct 09;3:10. doi: 10.1186/1751-0759-3-10.
Benzodiazepine prescription and length of hospital stay at a Japanese university hospital.
BioPsychoSocial medicine
Mutsuhiro Nakao, Mikiya Sato, Kyoko Nomura, Eiji Yano
PMID: 19818119
PMCID: PMC2765986 DOI: 10.1186/1751-0759-3-10
Abstract
BACKGROUND: The relationship between bed days and benzodiazepine prescription (BDZ) in Western countries is inconclusive, and no hospital-based report has documented this phenomenon in Japan. This study was done to assess the association between bed days and BDZ in a Japanese hospital.
METHODS: 21,489 adult patients (55.1% men, mean age 59.9 years old) hospitalized between April, 2005 and December, 2006 were enrolled in the study. Patient age, sex, ICD-10 diagnosis, prescription profile, and days of hospital stay were assessed in 13 non-psychiatric departments using a computer ordering system. Patients prescribed a benzodiazepine during hospitalization were defined as positive.
RESULTS: Of the total sample, 19.9% were allocated to the benzodiazepine (+) group. Female sex and older age were significant factors associated with benzodiazepine prescription. The median number of bed days was 13, and the likelihood of BDZ significantly increased with the number of bed days, even after controlling for the effects of age, gender, and ICD-10 diagnosis. For example, when the analysis was limited to patients with 50 bed days or longer, the percentage of BDZ (32.7%) was equivalent to that of a report from France.
CONCLUSION: Irrespective of department or disease, patients prescribed benzodiazepine during their hospital stay tended to have a higher number of bed days in the hospital. The difference in the prevalence of BDZ between this study and previous Western studies might be attributed to the relatively short length of hospital stay in this study. Because BDZs are often reported to be prescribed to hospitalized patients without appropriate documentation for the indications for use, it is important to monitor the rational for prescriptions of benzodiazepine carefully, for both clinical and economical reasons.
References
- J Clin Epidemiol. 2003 Oct;56(10):1021-6 - PubMed
- Int J Clin Pharmacol Ther. 2007 Jan;45(1):30-5 - PubMed
- Int J Clin Pharmacol Ther. 2005 Aug;43(8):411-2 - PubMed
- Psychiatr Serv. 2000 Oct;51(10):1278-81 - PubMed
- Pharmacoepidemiol Drug Saf. 2001 Oct-Nov;10(6):531-5 - PubMed
- Int J Clin Pharmacol Ther. 2005 Jul;43(7):339-49 - PubMed
- Intern Med. 2006;45(22):1279-83 - PubMed
- CMAJ. 1990 Mar 15;142(6):585-9 - PubMed
- BMJ. 2001 Mar 24;322(7288):704-8 - PubMed
- J Clin Psychiatry. 2004;65 Suppl 5:7-12 - PubMed
- Psychiatry Clin Neurosci. 2006 Oct;60(5):605-10 - PubMed
- J Gen Intern Med. 2007 Jul;22(7):1024-9 - PubMed
- J Clin Psychopharmacol. 2002 Jun;22(3):285-93 - PubMed
- Eur J Clin Pharmacol. 2005 Jun;61(4):291-5 - PubMed
- Best Pract Res Clin Anaesthesiol. 2003 Jun;17(2):219-33 - PubMed
- Intern Med. 2007;46(6):255-6 - PubMed
- J Pak Med Assoc. 2005 Jun;55(6):259-63 - PubMed
- J Affect Disord. 2006 Jan;90(1):29-35 - PubMed
- Med J Aust. 1996 Sep 16;165(6):305-8 - PubMed
- JAMA. 1997 Jan 22-29;277(4):301-6 - PubMed
- J Am Geriatr Soc. 1996 Nov;44(11):1371-4 - PubMed
- Am J Psychiatry. 1997 Dec;154(12):1766-8 - PubMed
- Drugs Aging. 1998 Jan;12(1):43-53 - PubMed
- J Ment Health Adm. 1997 Winter;24(1):90-7 - PubMed
- Tohoku J Exp Med. 2007 Jul;212(3):239-46 - PubMed
- Am J Med Qual. 1994 Fall;9(3):138-41 - PubMed
- Drug Saf. 1991 Jul-Aug;6(4):247-65 - PubMed
- BMJ. 1992 Apr 4;304(6831):881 - PubMed
- Arch Intern Med. 2004 Jul 26;164(14):1567-72 - PubMed
Publication Types